The mammea-type coumarin mammea E/BB (1) was found to inhibit both hypoxia-induced and iron chelator-induced hypoxia-inducible factor-1 (HIF-1) activation in human breast tumor T47D cells with IC 50 values of 0.96 and 0.89 µM, respectively. Compound 1 suppressed the hypoxic induction of secreted VEGF protein (T47D cells) and inhibited cell viability/proliferation in four human tumor cell lines. Compound 1 (at 5 and 20 µM) inhibited human breast tumor MDA-MB-231 cell migration. While the mechanisms that underlay their biological activities have remained unknown, prenylated mammea coumarins have been shown to be cytotoxic to human tumor cells, suppress tumor growth in animal models, and display a wide variety of antimicrobial effects. Mechanistic studies revealed that 1 appears to exert an assemblage of cellular effects by functioning as an anionic protonophore that potently uncouples mitochondrial electron transport and disrupts mitochondrial signaling in human tumor cell lines.The mammea-type coumarins are a large family of isoprenylated 5,7-dihydroxycoumarin metabolites from Mammea americana L. (Guttiferae/Clusiaceae) and other species of Mammea, Mesua, and Calophyllum.1 Mammea coumarins have been shown to possess a wide array of biological activities. These prenylated coumarins act as radical scavengers,2 are cytotoxic to human tumor cells,2 -6 suppress tumor growth in animal models,7 and exhibit anti-HIV,8 antifungal,9 and antibacterial4 , 10 activities. Recent studies indicate that the inhibitory effects exerted by mammea-type coumarins on tumor cell viability are mediated through mechanisms that involve mitochondrial dysfunction-mediated apoptosis, 7 , 11 , 12 and to a lesser degree necrotic cell death.7 However, the biochemical mechanisms by which this class of prenylated coumarins exerts such a broad range of effects on both eukaryotic and prokaryotic cells have remained unexplained. In a search for small-molecule HIF-1 inhibitors from natural sources, a lipid extract of the plant M. americana was found to inhibit hypoxia (1% O 2 )-induced HIF-1 activation by 89% at 5 µg/mL in a human prostate tumor PC-3 cell-based reporter assay. Bioassay-guided fractionation of the active extract resulted in the isolation of the previously reported mammea-type coumarin mammea E/BB (1).1 At submicromolar concentrations, 1 inhibited hypoxia-induced HIF-1 activation in human breast tumor T47D cells. Mechanistic studies have now revealed that 1 uncouples oxidative phosphorylation by suppressing the ability of cells to maintain the proton gradient
Results and DiscussionThe transcription factor HIF-1 regulates the expression of many genes involved in key aspects of cancer biology and has emerged as an important tumor-selective molecular target for anticancer drug discovery.15 Over 20,000 lipid extracts from plants and marine organisms were evaluated in tumor cell-based reporter assays for HIF-1 inhibitory activities. 16 An active extract of the plant M. americana was subjected to bioassay-guided isolation to yield th...